428 related articles for article (PubMed ID: 38104307)
1. Potential of Nano-Engineered Stem Cells in the Treatment of Multiple Sclerosis: A Comprehensive Review.
Ghosh S; Bhatti GK; Sharma PK; Kandimalla R; Mastana SS; Bhatti JS
Cell Mol Neurobiol; 2023 Dec; 44(1):6. PubMed ID: 38104307
[TBL] [Abstract][Full Text] [Related]
2. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
Dulamea AO
Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
[TBL] [Abstract][Full Text] [Related]
3. Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.
Xiao J; Yang R; Biswas S; Zhu Y; Qin X; Zhang M; Zhai L; Luo Y; He X; Mao C; Deng W
Mol Neurobiol; 2018 Apr; 55(4):3152-3171. PubMed ID: 28466274
[TBL] [Abstract][Full Text] [Related]
4. The Molecular Basis for Remyelination Failure in Multiple Sclerosis.
Gruchot J; Weyers V; Göttle P; Förster M; Hartung HP; Küry P; Kremer D
Cells; 2019 Aug; 8(8):. PubMed ID: 31382620
[TBL] [Abstract][Full Text] [Related]
5. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
Olsen JA; Akirav EM
J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
[TBL] [Abstract][Full Text] [Related]
6. Remyelinating strategies in multiple sclerosis.
Luessi F; Kuhlmann T; Zipp F
Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
[TBL] [Abstract][Full Text] [Related]
7. Myelin repair strategies: a cellular view.
Gallo V; Armstrong RC
Curr Opin Neurol; 2008 Jun; 21(3):278-83. PubMed ID: 18451710
[TBL] [Abstract][Full Text] [Related]
8. Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination.
Pusic AD; Kraig RP
Glia; 2014 Feb; 62(2):284-99. PubMed ID: 24339157
[TBL] [Abstract][Full Text] [Related]
9. Cell replacement therapy with stem cells in multiple sclerosis, a systematic review.
Christodoulou MV; Petkou E; Atzemoglou N; Gkorla E; Karamitrou A; Simos YV; Bellos S; Bekiari C; Kouklis P; Konitsiotis S; Vezyraki P; Peschos D; Tsamis KI
Hum Cell; 2024 Jan; 37(1):9-53. PubMed ID: 37985645
[TBL] [Abstract][Full Text] [Related]
10. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
Tepavčević V; Lubetzki C
Brain; 2022 Dec; 145(12):4178-4192. PubMed ID: 36093726
[TBL] [Abstract][Full Text] [Related]
11. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
12. Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
Rone MB; Cui QL; Fang J; Wang LC; Zhang J; Khan D; Bedard M; Almazan G; Ludwin SK; Jones R; Kennedy TE; Antel JP
J Neurosci; 2016 Apr; 36(17):4698-707. PubMed ID: 27122029
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances on Immunosuppressive Drugs and Remyelination Enhancers for the Treatment of Multiple Sclerosis.
Cadenas-Fernández J; Ahumada-Pascual P; Andreu LS; Velasco A
Curr Pharm Des; 2021 Oct; 27(30):3273-3280. PubMed ID: 33504299
[TBL] [Abstract][Full Text] [Related]
14. Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.
Zhang M; Ma Z; Qin H; Yao Z
Mol Neurobiol; 2016 Sep; 53(7):4406-16. PubMed ID: 26243185
[TBL] [Abstract][Full Text] [Related]
15. Engineering biomaterial microenvironments to promote myelination in the central nervous system.
Unal DB; Caliari SR; Lampe KJ
Brain Res Bull; 2019 Oct; 152():159-174. PubMed ID: 31306690
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial changes within axons in multiple sclerosis: an update.
Campbell GR; Ohno N; Turnbull DM; Mahad DJ
Curr Opin Neurol; 2012 Jun; 25(3):221-30. PubMed ID: 22543429
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis.
Jurynczyk M; Jurewicz A; Bielecki B; Raine CS; Selmaj K
J Neuroimmunol; 2005 Dec; 170(1-2):3-10. PubMed ID: 16290267
[TBL] [Abstract][Full Text] [Related]
18. Promoting remyelination in multiple sclerosis: current drugs and future prospects.
Kremer D; Küry P; Dutta R
Mult Scler; 2015 Apr; 21(5):541-9. PubMed ID: 25623245
[TBL] [Abstract][Full Text] [Related]
19. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
Qin J; Sikkema AH; van der Bij K; de Jonge JC; Klappe K; Nies V; Jonker JW; Kok JW; Hoekstra D; Baron W
J Neurosci; 2017 Oct; 37(41):9925-9938. PubMed ID: 28899916
[TBL] [Abstract][Full Text] [Related]
20. Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications.
Simkins TJ; Duncan GJ; Bourdette D
Curr Neurol Neurosci Rep; 2021 Apr; 21(6):26. PubMed ID: 33835275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
